Stem cells to cure COVID-19 because why not
Israeli scientists discovered a cure for coronavirus! Their proprietary PLX cells from placenta deliver 100% survival rate both against COVID-19 and a nuclear holocaust. The stocks soar.
By Leonid Schneider, on research integrity, biomedical ethics and academic publishing
Israeli scientists discovered a cure for coronavirus! Their proprietary PLX cells from placenta deliver 100% survival rate both against COVID-19 and a nuclear holocaust. The stocks soar.
Euroimmun founder Winfried Stöcker replies to criticism of his company’s publications: “Dr. Elisabeth Bik’s observations are not suitable to bring us into disrepute.”
EuroImmun is a German diagnostics biotech, founded by the most charming Professor Stöcker and recently sold to PerkinElmer. Elisabeth Bik checked some of company’s papers, many coauthored by Stöcker himself, and she raised questions. The company says this “testifies to a lack of knowledge of the matter”.
First gene-edited human babies were allegedly born, two twin girls. Jiankui He, associate professor at the South University of Science and Technology of China claimed to have used CRISPR gene editing technology, in a registered clinical trial, to make babies resistant to HIV. Did this really happen? In any case, everyone now takes distance to He.
This is my review of the Russian book “Megagrant”, which tells of Macchiarini’s adventures with the plastic trachea, much of it played out in Russia, funded by a state Megagrant of €4.5mn. Some books are namely only good as court evidence.
Janine Erler is a star of Danish cancer research, funded by ERC. Her earlier research led to the discovery of the key role of the enzyme lysyl oxidase in cancer metastasis and brought the scientist and businesswoman very close to curing cancer. Until some sad envious bad-wishers found duplicated gel bands in Erler papers.
Yesim Cetir was a young woman from Turkey, whose vulnerability the scandal surgeon used to test his plastic trachea (twice),Continue Reading
Sonia Melo is back, and not to be messed with. The Portuguese zombie scientist is responsible for a number ofContinue Reading
What with the EU phase 2 clinical trial TETRA going nowhere, the technology’s owner, Liverpool-based company Videregen decided to seek new clinical partners. Surgeons and universities from outside the EU are invited to test Videregen’s trachea transplant technology, which was originally developed together with Paolo Macchiarini by the UCL laryngologist and paid Videregen advisor Martin Birchall.
The pharma giant Pfizer announced to continue investigating the data manipulations committed by their former cancer researcher Min-Jean Yin, retractionsContinue Reading








